PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
18-Apr-2023 NIPPON KINZOKU has Commercialized Small-Diameter Tubes with “Inner Surface Precision” Businesswire
18-Apr-2023 New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023 Businesswire
18-Apr-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
18-Apr-2023 Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference Businesswire
18-Apr-2023 Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023 Businesswire
18-Apr-2023 Carbios beschleunigt Enzymoptimierung mit einer erhöhten Screening-Kapazität von mehreren Millionen Enzymen pro Tag Businesswire
18-Apr-2023 Carbios Accelerates Its Enzyme Optimization With Screening Capabilities for Millions of Enzymes in a Day Businesswire
18-Apr-2023 Capable de cribler des millions d’enzymes en un jour, Carbios démultiplie ses capacités d’optimisation d’enzymes Businesswire
18-Apr-2023 Armis anuncia un importante impulso comercial en el sector sanitario Businesswire
18-Apr-2023 Armis annonce un dynamisme commercial soutenu dans les soins de santé Businesswire
18-Apr-2023 Armis meldet signifikante Geschäftsdynamik im Gesundheitswesen Businesswire
18-Apr-2023 Armis anuncia uma dinâmica de negócios significativa nos serviços de saúde Businesswire
18-Apr-2023 Riassunto: Armis annuncia una forte crescita commerciale nel comparto sanitario Businesswire
18-Apr-2023 Samenvatting: Armis kondigt een belangrijk bedrijfsmomentum in de gezondheidszorg aan Businesswire
17-Apr-2023 Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee Businesswire
17-Apr-2023 Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023 Businesswire
17-Apr-2023 Toku Inc. Series A Preferred Investment Round Led by National Vision, Inc. and Topcon Healthcare Businesswire
17-Apr-2023 Dyve Announces Poster Presentation at 2023 AACR Annual Meeting Businesswire
17-Apr-2023 BeiGene and SpringWorks Present Clinical Data on Lifirafenib, in Combination with Mirdametinib, in Patients with Advanced or Refractory Solid Tumors with MAPK Pathway Aberrations at the American Association for Cancer Research Annual Meeting 2023 Businesswire
17-Apr-2023 MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors at the American Association for Cancer Research Annual Meeting 2023 Businesswire